Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized double-blind placebo-controlled phase III trial of pilocarpine hydrochloride ophthalmic solution in adult presbyopia
CTR20241911Phase 3Terminated
- Sponsor
- CSPC Ouyi Pharmaceutical
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pilocarpine in presbyopia, sponsored by CSPC Ouyi Pharmaceutical. Started May 2024; status: terminated.
02
Drugs
pilocarpine
03
Conditions
presbyopia
Beyond the preview
Go deeper on CTR20241911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241911.